BrainChild Bio spins out of Seattle Children's to develop cancer drugs
BioPharma
Stay updated with breaking news from Steve Brugger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Chaplain Joe," a New Mexico native and U.S. Air Force veteran, turned to helping homeless people several years ago as a volunteer at the Interfaith Community Shelter at Pete’s Place.
/PRNewswire/ -- BioNJ is pleased to host its 13th Annual BioPartnering Conference on Tuesday, April 18, 2023, at The Palace at Somerset Park, Somerset, NJ....
(Getty / E+ / Geber86) After getting off a meaty $120 million round in April, the height of the first wave of COVID-19 infections in the West, Affinivax is a clear indicator that infectious disease and vaccine work is here to stay. Nearly doubling that already impressive B round, the Cambridge, Massachusetts-based biotech has nabbed $226 million, with goals of unseating Pfizer’s Prevnar franchise as well as pushing a set of vaccines for hospital-associated infections into the clinic. Its lead program works as a Prevnar 13 challenger that covers 24 strains of pneumococcus and is full...